tirzepatide for thyroid and function in adults with type 2 diabetes or obesity: a systematic evidence map and data gap analysis Tirzepatide and levothyroxine: guide to

Ook diabetespatinten vallen af, al is dat in mindere mate aangezien ze een lagere dosis nemen

Researchers trying to understand how the metabolic environment a compound creates can affect reward-driven behavior patterns

Type 2 diabetes occurs when the body does not produce enough insulin or cannot use it effectively

No differences were observed in the prevalence of hypertension, atrial fibrillation or sleep apnea by obesity class, but patients with increased severity of obesity were less likely to have history of coronary artery disease

Orforglipron is now FDA-approved as Foundayo (approved April 1, 2026) and is available through LillyDirect, telehealth providers, and US retail pharmacies